【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q1 2013 9
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q1 2013 9
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q1 2013 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q1 2013 12
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q1 2013 13
2.4.1 Biogen Idec To Acquire Elan’s Interest In Multiple Sclerosis Drug Tysabri For $3.25 Billion 13
2.4.2 Medtronic Completes Public Offering of Notes for $3 Billion 13
2.4.3 Cardinal Health to Acquire AssuraMed for up to $2.07 Billion 14
2.4.4 Mylan to Acquire Agila Specialties from Strides Arcolab for up to $1.85 Billion 14
2.4.5 MacroGenics Enters into Licensing Agreement with Gilead Sciences for DART Technology 14
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 15
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q1 2013 15
3.1.1 Top M&A Deals in Q1 2013 16
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q1 2012 – Q1 2013 17
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q1 2013 18
3.2.1 Top Initial Public Offerings in Q1 2013 19
3.2.2 Top Secondary Offerings in Q1 2013 19
3.2.3 Top PIPE Deals in Q1 2013 19
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q1 2012–Q1 2013 20
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q1 2012 – Q1 2013 21
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q1 2013 22
3.3.1 Top Venture Financing Deals in Q1 2013 23
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2013 24
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q1 2013 25
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q1 2012 – Q1 2013 26
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 27
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 28
3.3.7 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q1 2013 29
3.3.8 Top Private Equity Deals in Q1 2013 30
3.3.9 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q1 2012 – Q1 2013 31
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2013 32
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q1 2013 32
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q1 2012 – Q1 2013 34
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2013 35
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q1 2013 36
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q1 2013 36
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q1 2013 37
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 38
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q1 2012 – Q1 2013 39
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q1 2012 – Q1 2013 40
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 41
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q1 2013 42
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q1 2013 42
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q1 2012 – Q1 2013 43
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q1 2013 44
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q1 2013 44
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q1 2013 45
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q1 2012 – Q1 2013 46
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q1 2012 – Q1 2013 47
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2012 – Q1 2013 48
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q1 2012 – Q1 2013 49
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q1 2012 – Q1 2013 50
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 51
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q1 2012 – Q1 2013 51
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q1 2012 – Q1 2013 52
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q1 2012 – Q1 2013 53
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q1 2012 – Q1 2013 54
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q1 2012 – Q1 2013 55
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q1 2012 – Q1 2013 56
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q1 2012 – Q1 2013 57
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 58
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q1 2013 58
7.1.1 Oncology – Deals of the Quarter 59
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q1 2013 60
7.2.1 Central Nervous System – Deals of the Quarter 61
7.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q1 2013 62
7.3.1 Immunology – Deals of the Quarter 63
7.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q1 2013 64
7.4.1 Infectious Disease – Deals of the Quarter 65
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q1 2013 66
7.5.1 Metabolic Disorders – Deals of the Quarter 67
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q1 2013 68
7.6.1 Cardiovascular – Deals of the Quarter 69
7.7 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q1 2013 70
7.7.1 Respiratory – Deals of the Quarter 71
7.8 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q1 2013 72
7.8.1 Gastrointestinal – Deals of the Quarter 73
7.9 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q1 2013 74
7.9.1 Ophthalmology – Deals of the Quarter 75
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q1 2013 76
7.10.1 Dermatology – Deals of the Quarter 77
8 Deal Summary by Geography 78
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q1 2013 78
8.1.1 North America – Deals of the Quarter 79
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q1 2013 80
8.2.1 Europe – Deals of the Quarter 81
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q1 2013 83
8.3.1 Asia-Pacific – Deals of the Quarter 84
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q1 2013 85
8.4.1 Rest of the World – Deals of the Quarter 86
9 Pharmaceuticals & Healthcare, Global, Top Advisors 87
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 87
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 88
10 Appendix 89
11 Further Information 92
11.1 Methodology 92
11.2 About GlobalData 93
11.3 Contact Us 93
11.4 Disclosure information 93
11.5 Disclaimer 93
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向（四半期別）：Q1 2013■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013
■ 発行日：2013年4月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160890
■ 調査対象地域：グローバル
- 外傷固定：グローバル市場分析と予測MediPoint: Trauma Fixation - Global Analysis and Market Forecasts Summary Traumatic injury patients that come into the Emergency Room (ER) experience orthopedic injury in the form of fractures 60% to 65% of the time, based on GlobalData’s conversations with key opinion leaders. Of this population, 45%–50% are operable and require fracture repair techniques in the form of external or internal fixat …
- POC検査装置の世界市場分析・予測MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts Summary Point-of-care testing (POCT), as known as bedside/near-patient testing is one of the most rapidly growing areas in IVD. Systems that are categorized as POC include the following - - Disposable systems or devices, which vary from reagent test strips for a single analyte to multi-analyte reagent strips - Small analyz …
- 発電機レンタルの世界市場：燃料（ディーゼル、ガス）、電力定格、エンドユーザー、用途、地域別分析The global power rental market is projected to reach USD 21.25 Billion by 2021, growing at a CAGR of 10.7% from 2016 to 2021. This growth can be attributed to the lack of electricity supply, rise in construction and infrastructural activities, and increase in number of planned events, triggering an increasing demand for energy. The report segments the power rental market on the basis of end-users …
- ドローン識別システムの世界市場予測（～2022）The drone identification market is estimated to grow from USD 801.8 Million in 2016 to USD 15,968.2 Million by 2022, at a CAGR of 64.64% from 2016 to 2022. Need for countermeasure systems to detect counter drones and identification systems to detect unregulated commercial drones hovering in airspace are the factors fueling the growth of the drone identification market. Based on application, the dr …
- グローバル水可溶性肥料市場分析と予測Water-soluble fertilizers are fertilizers that can be dissolved in water and added or leached out of the soil easily. It is easy to control the precise amount of nutrients available to plants with the help of water-soluble fertilizers. In terms of volume, the water-soluble fertilizers market is estimated to grow at a CAGR of 5.3% from 2013 to 2018, reaching 9,251.2 thousand metric tons by 2018. Th …
- 炭化ホウ素の世界市場Boron Carbide (CAS 12069-32-8) Market Research Report 2013 presents comprehensive data on Boron carbide markets globally and regionally (Europe, Asia, North America etc.) The Boron Carbide (CAS 12069-32-8) Market Research Report 2013 includes Boron carbide description, covers its application areas and related patterns. It overviews Boron carbide market, names Boron carbide producers and indicates …
- 電動サンルーフの世界市場予測（～2025年）“Increasing sales of premium vehicles in developed regions and growing demand for electric and hybrid vehicles across the globe to fuel the demand for power sunroof market”The global power sunroof market is projected to grow at a CAGR of 10.81% from 2017 to 2025, to reach USD 11.60 billion by 2025 from 5.10 billion in 2017. The major factors driving the growth of the market include advancements in …
- セキュリティインテリジェンスおよび分析ソリューションの世界市場2016-2020About the Security Intelligence and Analytics Solutions Market Security intelligence helps preventing attacks such as advanced persistent threat and advanced malware. These emerging cyber-attacks are immune to the traditional security methods. Organizations need a proactive intelligent system to prevent these attacks, as they can lead to misuse or tampering of data. Security intelligence service i …
- 世界の特殊脅威分析及び防御市場（ITセキュリティー）：Global Specialized Threat Analysis and Protection Market 2014-2018TechNavio forecasts The Global Specialized Threat Analysis and Protection Market 2014-2018 with a CAGR of 41.3 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a nu …
- 遠隔患者監視装置の世界市場分析：製品別（生存兆候モニター、専門モニター）、エンドユーザー別（病院の患者、その他（外来患者、在宅医療））、用途別、セグメント予測、2014-2025Global remote patient monitoring devices market is expected to reach USD 1.9 billion by 2025, according to a new report by Grand View Research Inc. Remote patient monitoring devices, due to their capability to monitor various chronic conditions such as diabetes, cardiovascular conditions and cancer are expected to witness substantial growth over the forecast period. Increasing incidences of cardio …
- 建築用塗料の世界市場：水性塗料、溶剤型塗料About Architectural Coatings Coatings are products used to protect a surface and/or enhance its appearance. Architectural coatings are applied to commercial and residential buildings to protect them from elements such as moisture, UV radiation, and microbes. Paints, primers, lacquers, varnishes, and stains are some of the major types of architectural coatings. These are formulated using various ty …
- Frontier Pharma: Systemic Lupus Erythematosus – Identifying and Commercializing First-in-Class InnovationFrontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation Summary The Systemic Lupus Erythematosus (SLE) drug market is currently under-served by non-generic, targeted therapies. Whilst the only Food and Drug Administration (FDA)-approved biologic, Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s perfor …
- 世界の主要感染症スクリーニング検査（医療機器）市場This unique report from Venture Planning Group provides sales and market share estimates for major suppliers of infectious disease testing products by assay and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, an …
- 世界のムコン酸市場2015The Global Muconic Acid Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Muconic Acid industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Muconic Acid market analysis is provided for the international markets including development trends, competitive …
- 世界の女性衛生用品市場：ニュース、イベント動向（2014年3月）Synopsis The report provides a review of the latest news and key events in the global feminine hygiene market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global feminine hygiene market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events i …
